# Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

> **NCT05790252** · PHASE3 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 40 (estimated)

## Conditions studied

- Opioid Use Disorder
- Pregnancy Related
- Pregnancy, High Risk
- Pregnancy Complications
- Buprenorphine Withdrawal

## Interventions

- **DRUG:** Buprenorphine Transdermal Matrix Patch
- **OTHER:** Sham patch

## Key facts

- **NCT ID:** NCT05790252
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-27
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05790252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05790252, "Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05790252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*